Hepatitis A is a viral infection which can cause severe liver disease. The viral infection is usually spread by contaminated food and water.
Travellers will receive an active vaccine. This is a purified, inactivated preparation of hepatitis A virus.
Those travelling to or who will be residing in areas where the disease is common, particularly if sanitation and food hygiene is likely to be poor. Additional vaccine information: The vaccine is also available combined with hepatitis B or typhoid.
A single injection 2 weeks prior to travel. Then a reinforcing dose 6-12 months later.
2 weeks before travel
General issues: Patients who have had a serious reaction (”anaphylaxis”) to a previous dose of this vaccine or its constituents. Specific issues: One brand of vaccine ”Epaxal” should not be given to those who have had anaphylaxis to hens’ eggs.
There is no evidence of risk.
25 years
Very few. Temporary tenderness at the site of the injection.
£82 per dose
Diphtheria is usually spread by close contact with infected persons. In the UK, the combined Diptheria/Tetanus/Polio vaccine is recommended when diphtheria boosters are indicated for adults. A diphtheria booster lasts 10 years. Tetanus is a serious infection, usually contracted following contamination of wounds. In the UK, after 5 doses of vaccine, tetanus boosters are not routinely required unless travelling to areas with limited medical care. In the UK, the combined Diptheria/Tetanus/Polio vaccine is recommended when tetanus boosters are indicated. A tetanus booster lasts 10 years.
Given as a combined vaccine with polio, tetanus and diphtheria.
Those travelling to an area with poor access to medical attention who have not had a booster in the last 10 years. Additional vaccine information: If your childhood schedule was incomplete, seek guidance about additional doses. In the UK, tetanus vaccine is combined with polio and diphtheria.
A single injection.
2 weeks before travel
General issues: Patients who have had a serious reaction (”anaphylaxis”) to a previous dose of this vaccine or its constituents. Specific issues: Unstable epilepsy.
There is no evidence of risk.
10 years
Very few. Temporary tenderness at the site of the injection
£50 per dose
Hepatitis B is a viral infection which can cause serious liver disease. It is usually spread sexually and by contact with infected blood or body fluids (e.g. puncture of the skin with contaminated needles). Vaccination is recommended for long-stay travellers, and those at risk due to their medical history, activities or work.
Travellers to areas of high or intermediate prevalence who place themselves at risk when abroad should be offered immunisation. The behaviours that place them at risk will include sexual activity, injecting drug use, undertaking relief aid work and/or participating in contact sports. Travellers are also at risk of acquiring infection as a result of medical or dental procedures carried out in countries where unsafe therapeutic injections are a possibility.
Additional vaccine information: The vaccine is available combined with hepatitis A vaccine.
Those travelling to an area with poor access to medical attention who have not had a booster in the last 10 years. Additional vaccine information: If your childhood schedule was incomplete, seek guidance about additional doses. In the UK, tetanus vaccine is combined with polio and diphtheria.
There are several different schedules of vaccination. Usually we advise three doses at 0, 1 and 6 months.
2 months before travel
General issues: Patients who have had a serious reaction (”anaphylaxis”) to a previous dose of this vaccine or its constituents. Specific issues: Vaccination should not replace other protective measures against infection, for example the use of condoms.
There is no evidence of risk.
Life cover after a full 3 dose course
Very few. Temporary tenderness at the site of the injection
£62 per dose
Yellow Fever is spread by mosquitoes and is found in tropical parts of Africa and South America. Some countries require proof of yellow fever vaccination in the form of an International Certificate of Vaccination before they allow a traveller to enter. Failure to provide a valid certificate can lead to a traveller being quarantined, immunised or denied entry.
A LIVE attenuated (weakened) strain of Yellow Fever virus.
Persons aged nine months or older who are travelling to countries that require an International Certificate of Vaccination for entry, or who are travelling to or living in infected areas or countries in the yellow fever endemic zone even if these countries do not require evidence of immunisation on entry. Additional vaccine information: Only a licenced Yellow Fever Centre can provide vaccination. Travellers will require an International Certificate of Vaccination prior to travel to countries where the disease is found. The certificate only becomes valid 10 days after injection. Travellers should factor this in to their plans.
A single injection.
2 weeks before travel
General issues: There is a risk of a rare but serious adverse event, which particularly affects infants and older patients. Vaccination should only be provided after a careful assessment of health and travel plans by the clinic. Specific issues: HIV infected patients should not be vaccinated. Patients with thymus disease should not be vaccinated. Those who have received a live vaccination within the last 4 weeks eg MMR or BCG should delay Yellow Fever vaccination by one month. However live vaccines can be given together on the same day.
The vaccine may not be given to pregnant women. In breast feeding, there is no evidence of harm to the baby, but the need for vaccination requires careful assessment.
Life long
Adverse reactions following yellow fever vaccine are typically mild and consist of headache, muscle pain, low grade fever and/or soreness at the injection site. This occurs in about 10 to 30% of recipients.
£85 per dose
Typhoid fever is a bacterial infection usually spread by contaminated food and water. It can cause a serious illness, but vaccines offer up to 80 % protection.
There are two types of vaccine available: an injectable and an oral variety. We recommend the use of the injectable variety.
Travellers to countries where typhoid is common, especially if staying with or visiting the local population, or with frequent and/or prolonged exposure to conditions where sanitation and food hygiene are likely to be poor. Additional vaccine information: The vaccine is available in a combined preparation with Hepatitis A.
A single dose by injection.
2 weeks before travel
General issues: Patients who have had a serious reaction (”anaphylaxis”) to a previous dose of this vaccine or its constituents. Specific issues: If you decide to have the oral preparation, you should discuss malaria treatment with the clinician
There is no data available about safety in pregnancy and breast feeding. So, subject to medical assessment, vaccine is not recommended for pregnant or breast feeding women.
3 years
Very few. Temporary tenderness at the site of the injection. Some patients describe temporary headache and nausea.
£56 per dose
Essential | Optional | |
---|---|---|
Vaccination | All travellers | When to get vaccinated |
Hepatitis A Vaccination | 2 weeks before travel | |
Combined Diptheria, Tetanus & Polio Vaccination | 2 weeks before travel | |
Hepatitis B Vaccination | 2 months before travel | |
Yellow Fever Vaccination | 2 weeks before travel | |
Typhoid Vaccination | 2 weeks before travel | |
Please note the above is a guide only. Every journey is unique and should be fully checked with our qualified pharmacists, or healthcare team, before you travel overseas. Disease can vary across a single country and vaccination requirements may differ by local area. Book a consultation with us now to establish the recommended vaccinations and medication for your chosen destination(s) |
© Smarta Healthcare 2024. All rights reserved